Home › Funds › ABG-WTT Global Life Science Capital Partners GP Ltd › CBLL
ABG-WTT Global Life Science Capital Partners GP Ltd position in CBLL
CERIBELL INC · Health Care
ABG-WTT Global Life Science Capital Partners GP Ltd reported holding 275,328 shares of CBLL (CERIBELL INC) in its Q2 2026 13F filing — a position valued at US$5.4M, representing 62.61% of its reported portfolio and ranking #1 among its reported holdings. ABG-WTT Global Life Science Capital Partners GP Ltd has disclosed CBLL holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ABG-WTT Global Life Science Capital Partners GP Ltd's CBLL position evolved
ABG-WTT Global Life Science Capital Partners GP Ltd first disclosed a stake in CBLL in Q4 2024 at 1,088,101 shares (US$28.2M). Across 7 filings, ABG-WTT Global Life Science Capital Partners GP Ltd increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 275,328 shares valued at US$5.4M — a reduction of -166,492 shares quarter over quarter.. Notable position changes include a 59% trim in Q4 2025 (shares fell 16% over the following quarter), a 38% trim in Q2 2026 (shares rose 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.09M | $28.16M | New |
| Q1 2025 | 1.09M | $20.90M | Hold |
| Q2 2025 | 1.09M | $20.38M | Hold |
| Q3 2025 | 1.09M | $12.50M | Hold |
| Q4 2025 | 441.82K | $9.69M | Reduce |
| Q1 2026 | 441.82K | $8.10M | Hold |
| Q2 2026 | 275.33K | $5.36M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CBLL and 13F data
CBLL (CERIBELL INC) is a Health Care company. 60 other funds we track also report a position in CBLL — the largest reported positions include TPG GP A, LLC (US$73.2M), Red Tree Management, LLC (US$53.8M), KCM Capital Inc (US$21.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CBLL
- TPG GP A, LLC 3.76M sh · $73.15M · Q2 2026
- Red Tree Management, LLC 2.21M sh · $53.80M · Q3 2026
- KCM Capital Inc 1.12M sh · $21.88M · Q2 2026
- Redmile Group, LLC 386.79K sh · $7.52M · Q2 2026
- Yu Fan 342.40K sh · $6.66M · Q2 2026
- Creek Drive Management Group LLC 300.88K sh · $5.85M · Q2 2026
More on ABG-WTT Global Life Science Capital Partners GP Ltd
FAQ
How long has ABG-WTT Global Life Science Capital Partners GP Ltd held CBLL?
ABG-WTT Global Life Science Capital Partners GP Ltd has disclosed CBLL holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is ABG-WTT Global Life Science Capital Partners GP Ltd's current position in CBLL?
As of Q2 2026, ABG-WTT Global Life Science Capital Partners GP Ltd holds 275.33K shares of CBLL (CERIBELL INC), valued at $5.36M, representing 62.61% of its reported portfolio and ranking #1.
Has ABG-WTT Global Life Science Capital Partners GP Ltd been buying or selling CBLL?
In the latest 13F filing (Q2 2026), ABG-WTT Global Life Science Capital Partners GP Ltd reduced its position in CBLL.
Which other funds hold CBLL?
Other major institutional holders of CBLL include TPG GP A, LLC, Red Tree Management, LLC, KCM Capital Inc, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.